Robert Hershberg,George Coukos,Gregory Dietsch,Andrea Facciabene,Kristi Manjarrez,Tressa D. Randall
申请号：
US13252147
公开号：
US20120219615A1
申请日:
2011.10.03
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention is directed generally to formulations of a TLR agonist preferably a TLR8 agonist, and its use in the treatment of various diseases, including combination therapies for treating cancer.
